DIGESTIVE AND LIVER DISEASE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2200441, encodeId=8099220044128, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胆管癌 经验分享：2023年4月初投的，月底给的返修，非常快，意见也比较中肯，补了很多实验，2个月返回去，一个周之内二修，返回去之后就接收了。接收之后proof也非常快，proof结束2天online了，选了非OA，23年8月28号online的，今年3月份publish，下个月应该能开出检索证明了。同组也中了一篇，选的OA，今年1月接收，到现在只是online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f96148029, createdName=ms7000001433627956, createdTime=Thu Apr 25 21:51:11 CST 2024, time=2024-04-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=925017, encodeId=a71692501e73, content=审稿速度:1.0 经验分享：中了一篇image of the month，前后花了两个月的时间，审稿人让加做了免疫组化，杂志不需要版面费还挺好的，一审大概就半个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Feb 17 11:31:39 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199123, encodeId=960b2199123c3, content=偏重的研究方向：肝细胞癌 经验分享：11号投的，当天给了稿号，目前还没消息，是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Thu Apr 18 14:42:04 CST 2024, time=2024-04-18, status=1, ipAttribution=河北), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢？这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗，我看images of the month栏目是以case report 的形式，有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=)]

2024-04-25 ms7000001433627956 来自山东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：胆管癌
经验分享：2023年4月初投的，月底给的返修，非常快，意见也比较中肯，补了很多实验，2个月返回去，一个周之内二修，返回去之后就接收了。接收之后proof也非常快，proof结束2天online了，选了非OA，23年8月28号online的，今年3月份publish，下个月应该能开出检索证明了。同组也中了一篇，选的OA，今年1月接收，到现在只是online了

2 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200441, encodeId=8099220044128, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胆管癌 经验分享：2023年4月初投的，月底给的返修，非常快，意见也比较中肯，补了很多实验，2个月返回去，一个周之内二修，返回去之后就接收了。接收之后proof也非常快，proof结束2天online了，选了非OA，23年8月28号online的，今年3月份publish，下个月应该能开出检索证明了。同组也中了一篇，选的OA，今年1月接收，到现在只是online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f96148029, createdName=ms7000001433627956, createdTime=Thu Apr 25 21:51:11 CST 2024, time=2024-04-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=925017, encodeId=a71692501e73, content=审稿速度:1.0 经验分享：中了一篇image of the month，前后花了两个月的时间，审稿人让加做了免疫组化，杂志不需要版面费还挺好的，一审大概就半个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Feb 17 11:31:39 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199123, encodeId=960b2199123c3, content=偏重的研究方向：肝细胞癌 经验分享：11号投的，当天给了稿号，目前还没消息，是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Thu Apr 18 14:42:04 CST 2024, time=2024-04-18, status=1, ipAttribution=河北), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢？这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗，我看images of the month栏目是以case report 的形式，有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=)]

2021-02-17 追风雨看彩虹

审稿速度:1.0
经验分享：中了一篇image of the month，前后花了两个月的时间，审稿人让加做了免疫组化，杂志不需要版面费还挺好的，一审大概就半个月的时间。

234 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200441, encodeId=8099220044128, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胆管癌 经验分享：2023年4月初投的，月底给的返修，非常快，意见也比较中肯，补了很多实验，2个月返回去，一个周之内二修，返回去之后就接收了。接收之后proof也非常快，proof结束2天online了，选了非OA，23年8月28号online的，今年3月份publish，下个月应该能开出检索证明了。同组也中了一篇，选的OA，今年1月接收，到现在只是online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f96148029, createdName=ms7000001433627956, createdTime=Thu Apr 25 21:51:11 CST 2024, time=2024-04-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=925017, encodeId=a71692501e73, content=审稿速度:1.0 经验分享：中了一篇image of the month，前后花了两个月的时间，审稿人让加做了免疫组化，杂志不需要版面费还挺好的，一审大概就半个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Feb 17 11:31:39 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199123, encodeId=960b2199123c3, content=偏重的研究方向：肝细胞癌 经验分享：11号投的，当天给了稿号，目前还没消息，是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Thu Apr 18 14:42:04 CST 2024, time=2024-04-18, status=1, ipAttribution=河北), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢？这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗，我看images of the month栏目是以case report 的形式，有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=)]

2024-04-18 ms9000002054407114 来自河北

偏重的研究方向：肝细胞癌
经验分享：11号投的，当天给了稿号，目前还没消息，是准备送外审了吗？

89 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200441, encodeId=8099220044128, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胆管癌 经验分享：2023年4月初投的，月底给的返修，非常快，意见也比较中肯，补了很多实验，2个月返回去，一个周之内二修，返回去之后就接收了。接收之后proof也非常快，proof结束2天online了，选了非OA，23年8月28号online的，今年3月份publish，下个月应该能开出检索证明了。同组也中了一篇，选的OA，今年1月接收，到现在只是online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f96148029, createdName=ms7000001433627956, createdTime=Thu Apr 25 21:51:11 CST 2024, time=2024-04-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=925017, encodeId=a71692501e73, content=审稿速度:1.0 经验分享：中了一篇image of the month，前后花了两个月的时间，审稿人让加做了免疫组化，杂志不需要版面费还挺好的，一审大概就半个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Feb 17 11:31:39 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199123, encodeId=960b2199123c3, content=偏重的研究方向：肝细胞癌 经验分享：11号投的，当天给了稿号，目前还没消息，是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Thu Apr 18 14:42:04 CST 2024, time=2024-04-18, status=1, ipAttribution=河北), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢？这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗，我看images of the month栏目是以case report 的形式，有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=)]

2020-10-18 1248756em59(暂无昵称)

审稿速度:1.0 | 投稿命中率:25.0
经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。

290 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200441, encodeId=8099220044128, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胆管癌 经验分享：2023年4月初投的，月底给的返修，非常快，意见也比较中肯，补了很多实验，2个月返回去，一个周之内二修，返回去之后就接收了。接收之后proof也非常快，proof结束2天online了，选了非OA，23年8月28号online的，今年3月份publish，下个月应该能开出检索证明了。同组也中了一篇，选的OA，今年1月接收，到现在只是online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f96148029, createdName=ms7000001433627956, createdTime=Thu Apr 25 21:51:11 CST 2024, time=2024-04-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=925017, encodeId=a71692501e73, content=审稿速度:1.0 经验分享：中了一篇image of the month，前后花了两个月的时间，审稿人让加做了免疫组化，杂志不需要版面费还挺好的，一审大概就半个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Feb 17 11:31:39 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199123, encodeId=960b2199123c3, content=偏重的研究方向：肝细胞癌 经验分享：11号投的，当天给了稿号，目前还没消息，是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Thu Apr 18 14:42:04 CST 2024, time=2024-04-18, status=1, ipAttribution=河北), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢？这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗，我看images of the month栏目是以case report 的形式，有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=)]

2024-02-12 ms6000000536352595 来自陕西省

images of the month和case有啥区别呢？这个杂志

148 0

[GetPortalCommentsPageByObjectIdResponse(id=2200441, encodeId=8099220044128, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胆管癌 经验分享：2023年4月初投的，月底给的返修，非常快，意见也比较中肯，补了很多实验，2个月返回去，一个周之内二修，返回去之后就接收了。接收之后proof也非常快，proof结束2天online了，选了非OA，23年8月28号online的，今年3月份publish，下个月应该能开出检索证明了。同组也中了一篇，选的OA，今年1月接收，到现在只是online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f96148029, createdName=ms7000001433627956, createdTime=Thu Apr 25 21:51:11 CST 2024, time=2024-04-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=925017, encodeId=a71692501e73, content=审稿速度:1.0 经验分享：中了一篇image of the month，前后花了两个月的时间，审稿人让加做了免疫组化，杂志不需要版面费还挺好的，一审大概就半个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Feb 17 11:31:39 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199123, encodeId=960b2199123c3, content=偏重的研究方向：肝细胞癌 经验分享：11号投的，当天给了稿号，目前还没消息，是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Thu Apr 18 14:42:04 CST 2024, time=2024-04-18, status=1, ipAttribution=河北), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢？这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗，我看images of the month栏目是以case report 的形式，有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=)]

2023-04-01 ms4000000223433444 来自山东省

digestive and liver disease是需要所有读者认证吗？求助

139 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200441, encodeId=8099220044128, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胆管癌 经验分享：2023年4月初投的，月底给的返修，非常快，意见也比较中肯，补了很多实验，2个月返回去，一个周之内二修，返回去之后就接收了。接收之后proof也非常快，proof结束2天online了，选了非OA，23年8月28号online的，今年3月份publish，下个月应该能开出检索证明了。同组也中了一篇，选的OA，今年1月接收，到现在只是online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f96148029, createdName=ms7000001433627956, createdTime=Thu Apr 25 21:51:11 CST 2024, time=2024-04-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=925017, encodeId=a71692501e73, content=审稿速度:1.0 经验分享：中了一篇image of the month，前后花了两个月的时间，审稿人让加做了免疫组化，杂志不需要版面费还挺好的，一审大概就半个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Feb 17 11:31:39 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199123, encodeId=960b2199123c3, content=偏重的研究方向：肝细胞癌 经验分享：11号投的，当天给了稿号，目前还没消息，是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Thu Apr 18 14:42:04 CST 2024, time=2024-04-18, status=1, ipAttribution=河北), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢？这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗，我看images of the month栏目是以case report 的形式，有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=)]

2023-08-21 左手摸机来自浙江省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！

137 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200441, encodeId=8099220044128, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胆管癌 经验分享：2023年4月初投的，月底给的返修，非常快，意见也比较中肯，补了很多实验，2个月返回去，一个周之内二修，返回去之后就接收了。接收之后proof也非常快，proof结束2天online了，选了非OA，23年8月28号online的，今年3月份publish，下个月应该能开出检索证明了。同组也中了一篇，选的OA，今年1月接收，到现在只是online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f96148029, createdName=ms7000001433627956, createdTime=Thu Apr 25 21:51:11 CST 2024, time=2024-04-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=925017, encodeId=a71692501e73, content=审稿速度:1.0 经验分享：中了一篇image of the month，前后花了两个月的时间，审稿人让加做了免疫组化，杂志不需要版面费还挺好的，一审大概就半个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Feb 17 11:31:39 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199123, encodeId=960b2199123c3, content=偏重的研究方向：肝细胞癌 经验分享：11号投的，当天给了稿号，目前还没消息，是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Thu Apr 18 14:42:04 CST 2024, time=2024-04-18, status=1, ipAttribution=河北), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢？这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗，我看images of the month栏目是以case report 的形式，有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=)]

2023-11-04 ms4000002096191420 来自广西

审稿速度:3.0 | 投稿命中率:50.0
经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月

126 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200441, encodeId=8099220044128, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胆管癌 经验分享：2023年4月初投的，月底给的返修，非常快，意见也比较中肯，补了很多实验，2个月返回去，一个周之内二修，返回去之后就接收了。接收之后proof也非常快，proof结束2天online了，选了非OA，23年8月28号online的，今年3月份publish，下个月应该能开出检索证明了。同组也中了一篇，选的OA，今年1月接收，到现在只是online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f96148029, createdName=ms7000001433627956, createdTime=Thu Apr 25 21:51:11 CST 2024, time=2024-04-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=925017, encodeId=a71692501e73, content=审稿速度:1.0 经验分享：中了一篇image of the month，前后花了两个月的时间，审稿人让加做了免疫组化，杂志不需要版面费还挺好的，一审大概就半个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Feb 17 11:31:39 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199123, encodeId=960b2199123c3, content=偏重的研究方向：肝细胞癌 经验分享：11号投的，当天给了稿号，目前还没消息，是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Thu Apr 18 14:42:04 CST 2024, time=2024-04-18, status=1, ipAttribution=河北), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢？这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗，我看images of the month栏目是以case report 的形式，有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=)]

2023-09-15 ms6000000656125557 来自云南省

这个期刊接受case report吗，我看images of the month栏目是以case report 的形式，有什么区别吗

141 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200441, encodeId=8099220044128, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：胆管癌 经验分享：2023年4月初投的，月底给的返修，非常快，意见也比较中肯，补了很多实验，2个月返回去，一个周之内二修，返回去之后就接收了。接收之后proof也非常快，proof结束2天online了，选了非OA，23年8月28号online的，今年3月份publish，下个月应该能开出检索证明了。同组也中了一篇，选的OA，今年1月接收，到现在只是online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f96148029, createdName=ms7000001433627956, createdTime=Thu Apr 25 21:51:11 CST 2024, time=2024-04-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=925017, encodeId=a71692501e73, content=审稿速度:1.0 经验分享：中了一篇image of the month，前后花了两个月的时间，审稿人让加做了免疫组化，杂志不需要版面费还挺好的，一审大概就半个月的时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Feb 17 11:31:39 CST 2021, time=2021-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199123, encodeId=960b2199123c3, content=偏重的研究方向：肝细胞癌 经验分享：11号投的，当天给了稿号，目前还没消息，是准备送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Thu Apr 18 14:42:04 CST 2024, time=2024-04-18, status=1, ipAttribution=河北), GetPortalCommentsPageByObjectIdResponse(id=892872, encodeId=f3378928e2f6, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：系统不会提示审阅进程，如果两周没回复应该就是送外审了，我22天一审被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3a62494846, createdName=1248756em59(暂无昵称), createdTime=Sun Oct 18 16:34:47 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187026, encodeId=2b9c218e02615, content=images of the month和case有啥区别呢？这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=87e25530273, createdName=ms6000000536352595, createdTime=Mon Feb 12 10:58:24 CST 2024, time=2024-02-12, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2123079, encodeId=fa9521230e9f9, content=digestive and liver disease是需要所有读者认证吗？求助, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200916/86250b9f6f2640758fbe808a053d0193/4ff28ecd75a84be4a6872cc3504359aa.jpg, createdBy=277e5418822, createdName=ms4000000223433444, createdTime=Sat Apr 01 00:27:15 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2153818, encodeId=b099215381874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：14号投稿，15号给的稿号，20号收到elsvier已送外审邮件，杂志官网不显示稿件状态！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Mon Aug 21 08:25:32 CST 2023, time=2023-08-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166690, encodeId=92e221666902d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志速度没有想象的那么快，编辑处理都等了1个多月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=932f5423080, createdName=ms4000002096191420, createdTime=Sat Nov 04 20:11:58 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2157904, encodeId=5cb0215e9042e, content=这个期刊接受case report吗，我看images of the month栏目是以case report 的形式，有什么区别吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d496480466, createdName=ms6000000656125557, createdTime=Fri Sep 15 22:33:37 CST 2023, time=2023-09-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2098346, encodeId=a44f2098346ec, content=请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKXPagp7uqiapxxwbtPhMf5YUh469rhicZ2hPj9icUkRqWVNfjicCibrSGvOhZtPmhXKjicJb4dAx6oc1g/132, createdBy=56a45271305, createdName=RamonaHWW, createdTime=Thu Nov 03 21:21:44 CST 2022, time=2022-11-03, status=1, ipAttribution=)]

2022-11-03 RamonaHWW

请教一下发过文章的各位，投稿将近20+d，现处于submission being processed for author状态是已经送审了嘛？

202 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务